Company intelligence / Profile preview

Bioqube Ventures

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Bioqube Ventures is an active life sciences venture capital firm investing in early-stage therapeutic innovation across Europe and the US. Its portfolio features several clinical-stage biotech companies with assets ranging from preclinical through Phase II trials. The firm does not conduct its own clinical trials.

Therapeutic areas: OncologyImmunologyInfectious Diseases
Modalities: Monoclonal antibodySmall moleculeBiologicAntibody-drug conjugateCell therapy
Industry: Investors

Partnerships

Strategic relationships with industry partners including Genmab for expertise and co-investment opportunities.

Beyond the preview

Go deeper on Bioqube Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioqube Ventures.

Explore the full profile